LISATA THERAPEUTICS, INC.

LSTA · Nasdaq · SIC 2834: Pharmaceutical Preparations
340
SEC Filings

Business Summary

PART I . Overview Lisata Therapeutics, Inc. (together with its subsidiaries, the Company) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other serious diseases. Our investigational product, certepetide (formerly known as LSTA1 or CEND-1), is designed to activate a novel uptake pathway (the C-end rule active transport mechanism) that allows co-administered or tethered (i.e., mo...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionLSTAdiscussed_in_filing Cybersecurity
topic_mentionLSTAdiscussed_in_filing Trusted Computing
topic_mentionLSTAdiscussed_in_filing Blockchain & Crypto
topic_mentionLSTAdiscussed_in_filing Regulation
topic_mentionLSTAdiscussed_in_filing Healthcare & Bio
topic_mentionLSTAdiscussed_in_filing Platform & Ecosystem
topic_mentionLSTAdiscussed_in_filing Sovereign & Government
topic_mentionLSTAdiscussed_in_filing Cybersecurity
topic_mentionLSTAdiscussed_in_filing Trusted Computing
topic_mentionLSTAdiscussed_in_filing Blockchain & Crypto
topic_mentionLSTAdiscussed_in_filing Regulation
topic_mentionLSTAdiscussed_in_filing Healthcare & Bio
topic_mentionLSTAdiscussed_in_filing Platform & Ecosystem
topic_mentionLSTAdiscussed_in_filing Sovereign & Government
topic_mentionLSTAdiscussed_in_filing Cybersecurity
topic_mentionLSTAdiscussed_in_filing Trusted Computing
topic_mentionLSTAdiscussed_in_filing Blockchain & Crypto
topic_mentionLSTAdiscussed_in_filing Regulation
topic_mentionLSTAdiscussed_in_filing Healthcare & Bio
topic_mentionLSTAdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310000320017-26-000023EDGAR80K words
2025-02-272024-12-310000320017-25-000011EDGAR
2024-02-292023-12-310000320017-24-000007EDGAR
2023-03-302022-12-310000320017-23-000011EDGAR
2022-03-222021-12-310000320017-22-000016EDGAR
2021-02-252020-12-310000320017-21-000043EDGAR
2020-03-052019-12-310000320017-20-000016EDGAR
2019-03-142018-12-310000320017-19-000024EDGAR
2018-03-222017-12-310000320017-18-000021EDGAR
2017-03-172016-12-310000320017-17-000008EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300000320017-25-000070EDGAR21K words
2025-08-072025-06-300000320017-25-000060EDGAR
2025-05-082025-03-310000320017-25-000030EDGAR
2024-11-122024-09-300000320017-24-000058EDGAR
2024-08-122024-06-300000320017-24-000051EDGAR
2024-05-092024-03-310000320017-24-000031EDGAR
2023-11-022023-09-300000320017-23-000063EDGAR
2023-08-142023-06-300000320017-23-000055EDGAR
2023-05-092023-03-310000320017-23-000028EDGAR
2022-11-102022-09-300000320017-22-000102EDGAR
2022-08-042022-06-300000320017-22-000057EDGAR
2022-05-052022-03-310000320017-22-000042EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001140361-26-013070EDGAR2K words
2026-03-090000320017-26-000020EDGAR
2026-02-270000320017-26-000012EDGAR
2026-01-270000320017-26-000008EDGAR
2026-01-210000320017-26-000006EDGAR
2025-11-060000320017-25-000069EDGAR
2025-10-140000320017-25-000066EDGAR
2025-10-080000320017-25-000063EDGAR
2025-08-070000320017-25-000059EDGAR
2025-07-150000320017-25-000048EDGAR

340 total filings indexed. 308 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000320017
TickerLSTA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f03ce76590b1b8c54b4c4872c09dff822e27e89ca23007c5be3efd4b0fe24fca
parent: cd4da4e2dd17303d39392c5a906691077e9c414ee9e93fcd133aa6db9710e265
content hash: 81711dd1432dc7da461184e42413c6e88f950688006925e0e8c265946801b59b
signed: 2026-04-13T04:46:06.780Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf